Publication

Ross HM, Weber LW, Wang S, Piskun G, Dyall R, Song P, Takechi Y, Nikolić-Zugic J, Houghton AN, Lewis JJ. 1997. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin Cancer Res. 3:2191–6.

Finger LR, Pu J, Wasserman R, Vibhakar R, Louie E, Hardy RR, Burrows PD, Billips LG. 1997. The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene. 197:177–87. doi:10.1016/s0378-1119(97)00260-6.

Vasović LV, Dyall R, Clynes RA, Ravetch JV, Nikolić-Zugic J. 1997. Synergy between an antibody and CD8+ cells in eliminating an established tumor. Eur J Immunol. 27:374–82. doi:10.1002/eji.1830270206.

Dyall R, Vasović LV, Molano A, Nikolić-Zugic J. 1995. CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens. Int Immunol. 7:1205–12. doi:10.1093/intimm/7.8.1205.

Harris DT, Schumacher MJ, Locascio J, Booth A, Bard J, Boyse EA. 1994. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantation. Bone Marrow Transplant. 14:63–8.

Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein P, Bard J, Boyse EA. 1994. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 13:135–43.

Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. 1993. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol. 265:C1015–29. doi:10.1152/ajpcell.1993.265.4.C1015.

Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, Shenker L, Bard J, Boyse EA. 1992. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A. 89:10006–10. doi:10.1073/pnas.89.21.10006.

Franklin CC, Sanchez V, Wagner F, Woodgett JR, Kraft AS. 1992. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc Natl Acad Sci U S A. 89:7247–51.

Gossett KA, Turnwald GH, Kearney MT, Greco DS, Cleghorn B. 1987. Evaluation of gamma-glutamyl transpeptidase-to-creatinine ratio from spot samples of urine supernatant, as an indicator of urinary enzyme excretion in dogs. Am J Vet Res. 48:455–7.

Kraft AS, Anderson WB. 1983. Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature. 301:621–3.

Runyan RB, Markwald RR. 1983. Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. Dev Biol. 95:108–14.

Wendt AG, Jones SE, Salmon SE. 1980. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. Cancer Treat Rep. 64:269–73.

Salmon SE, Wendt A, Jones SE, Jackson R, Giordano G, Miller R, Heusinkveld R, Moon TE. 1978. Treatment of early breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: initial results of a brief and effective adjuvant program. Recent Results Cancer Res. 68:98–104.

Crompton GK. 1977. Special problems of clinical trials in status asthmaticus [proceedings]. Br J Dis Chest. 71:242–4.

Proske U, Waite PM. 1974. Properties of types of motor units in the medial gastrochemius muscle of the cat. Brain Res. 67:89–101.

DiCioccio RA, Strauss N. 1971. Annealing studies of transcription in B. Subtilis. Biochem Biophys Res Commun. 45:212–8.